ADVERTISEMENT
News
Blood Thinner Recalled
12/10/2020
The recall affects 100-count anagrelide capsules, 1 mg (NDC 13668-462-01), from batch BFD1G001 (Exp. 12/21). The capsules were manufactured in India for Torrent Pharma and distributed throughout the United States and in Puerto Rico.
Torrent Pharma initiated the recall November 25, 2020. At press time, the FDA had not yet classified the recall.
Anagrelide is a prescription blood thinner indicated for the treatment of patients with thrombocythemia.
—Jolynn Tumolo